Neuraminic acid-specific modification and tritium labelling of gangliosides.
1. A crude ganglioside mixture and pure GM1 and GD1a from bovine brain grey matter were prepared on a large scale. 2. The C7- and G8-analogues of NeuNAc were prepared from Collocalia mucoid and their structures established by gas-liquid chromatography and mass spectrometry. 3. Using model compounds in addition to various gangliosides, the conditions for the periodate oxidation and subsequent borohydride reduction of gangliosides were investigated with regard to the yield of C7- and C8-analogues of NeuNAc and the integrity of other monosaccharides in the oligosaccharide chain. These conditions were optimised to yield maximum C8-NeuNAc production and low C7-NeuNAc formation. Thus products were obtained which closely resemble the native gangliosides. 4. Using boro [3H] hydride, ganglioside derivatives with high specific radioactivity were prepared for the first time, containing either NeuNAc and labelled C8-NeuNAc or mainly labelled C7-NeuNAc depending on the prevailing conditions.
D000818:Animals; D001894:Borohydrides; D001921:Brain; D002241:Carbohydrates / Q000032:analysis; D002417:Cattle; D005732:Gangliosides / Q000378:metabolism; D007553:Isotope Labeling; D009438:Neuraminic Acids; D009439:Neuraminidase / Q000378:metabolism; D010084:Oxidation-Reduction; D010504:Periodic Acid; D012794:Sialic Acids; D014316:Tritium
D001894:Borohydrides; D002241:Carbohydrates; D005732:Gangliosides; D009438:Neuraminic Acids; D012794:Sialic Acids; D014316:Tritium; D010504:Periodic Acid; D009439:Neuraminidase